Myriad UroSuite™

About 1 in 8 men will be diagnosed with #prostatecancer during their lifetime. It's crucial for patients to understand the aggressiveness of their cancer to avoid over and undertreatment. Prolaris® testing helps personalize treatment plans by identifying if a patient is a candidate for active surveillance, or if they should pursue treatment like surgery or radiation, or a combination. At Myriad, we're committed to enhancing patient outcomes and advancing prostate cancer care. Learn more about prostate cancer with our comprehensive eBook: https://brnw.ch/21wMj6b #ProstateCancerAwarenessMonth #Biomarkers #GeneticTesting

Dive into the latest JCO Precision Oncology Conversations podcast where Dr. Jonathan Tward shares insights from his JCO PO article on how a Cell-Cycle Risk (CCR) score can predict the benefit of adding androgen-deprivation therapy (ADT) to radiation therapy for newly diagnosed prostate cancer patients. 👉 Listen now! https://brnw.ch/21wM9x0 #biomarkers #genetictesting #prostatecancertreatment #prostatecancer

"We use Prolaris® testing on all our patients. We believe it has the best data for us in terms of actionable information as to who needs active surveillance, who needs actual treatment, and the intensity of the treatment. It's the only biomarker that we feel like has that information." - Dr. Angelo Baccala, featured in the Urology Times Viewpoint video series on biomarker utilization in prostate cancer treatment. Watch the full video: https://lnkd.in/gaWpwafi

Prolaris® testing can help patients and their healthcare providers understand if hormone therapy (ADT) would be an effective treatment option, or if patients can safely avoid it. By combining tools like Gleason score and PSA with a personalized tumor score, Prolaris testing provides personalized information about the patient's specific cancer. https://lnkd.in/gZAwdx-g #prostatecancer #genetictesting #biomarkers #hormonetherapy #urology

"The Prolaris® test is the only biomarker that provides a highly personal risk estimate of absolute risk reduction so the individual can really decide whether using or omitting ADT is right for them”. - Dr. Jonathan Tward, MD, PhD, FASTRO Learn more about how Prolaris testing is individualizing #prostatecancer treatment decisions: https://lnkd.in/gZAwdx-g #biomarkers #genetictesting #urology #radiationoncology #hormonetherapy

Tune into the latest #ACROPodcast where Dr. Hassanzadeh and Dr. Fairchild discuss advancements in prostate cancer care from the perspective of radiation oncology. Discover how they've integrated biomarker testing into their practices to offer personalized treatment information to their patients. #Biomarkers #Genetictesting #Prostatecancer #RadiationOncology

Check out a new peer exchange series by Urology Times, featuring leading experts in the field as they discuss the evolving role of biomarkers in prostate cancer. Don’t miss out on these insightful discussions! New episodes will be released weekly. https://lnkd.in/grQf342U #ProstateCancer #Biomarkers #GeneticTesting #Urology

While hormone therapy (ADT) can be effective at slowing the progression of #prostatecancer, it is often associated with side effects that can significantly diminish one’s quality of life. Prolaris® testing determines how much someone may benefit from ADT vs. the side effects, helping make more informed treatment decisions Learn how to implement Prolaris testing into your protocols today https://lnkd.in/ghWEnSGm #biomarker #genetictesting #hormonetherapy #precisionmedicine #radiationoncology

Prolaris® testing offers a comprehensive risk assessment by combining personalized tumor information with traditional clinical and pathological features like PSA and Gleason, helping healthcare providers tailor treatment plans to each #prostatecancer patient. Learn more by connecting with a Myriad Account Executive in your area today! https://lnkd.in/ghwnEkH6 #biomarkers #genetictesting #urology